Skip to main content

Table 2 Comparison between HBV DNA PCR results in the studied patients

From: Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)

N = 200 At the start of treatment After 1 month of treatment At the end of treatment P-value
HBV DNA PCR Negative 166 (83%) 159 (79.5%) 154 (77%) P1 = 0.253 NS
P2 = 0.064 NS
P3 = 0.475 NS
Positive 34 (17%) 41 (20.5%) 46 (23%)
  1. X2: chi-square test
  2. S: p-value < 0.05 is considered significant
  3. HS: p-value < 0.001 is considered highly significant
  4. P1: refers to the statistical difference between the start of DAA and 1 month after DAA
  5. P2: refers to the statistical difference between the start of DAA and the end of DAA
  6. P3: refers to the statistical difference between 1 month after DAA and the end of DAA